SCHEMBL533307

SCHEMBL533307

Cc1cc(C)c(N2CCCC2)c(C)c1NC(=O)c1ccccc1-c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
SUCNR1 Q9BXA5 1/20 0.41
POLB P06746 1/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 5/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
NPC1 O15118 2/20 0.40
GAA P10253 2/20 0.40
MAPT P10636 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TDP1 Q9NUW8 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532902 0.92 L3MBTL1 (0.43) MEN1KMT2ANPSR1CYP2C19CYP3A4
SCHEMBL532826 0.91 ALDH1A1 (0.47) NPSR1POLBLMNAALDH1A1L3MBTL1
SCHEMBL532809 0.90 ALDH1A1 (0.46) MEN1KMT2ANPSR1LMNAALDH1A1
SCHEMBL532940 0.88 GAA (0.50) MEN1KMT2ACYP2C19CYP2D6POLB
SCHEMBL14288688 0.87 MTTP (0.52) KMT2ALMNAALDH1A1GAAMAPT
SCHEMBL533116 0.86 MAPT (0.46) MEN1KMT2ANPSR1CYP2C19CYP3A4
SCHEMBL533536 0.85 L3MBTL1 (0.49) MEN1KMT2ANPSR1CYP2C19CYP3A4
SCHEMBL532950 0.85 KMT2A (0.56) MEN1KMT2ANPSR1CYP2C19CYP3A4
SCHEMBL533064 0.83 MAPT (0.56) MEN1KMT2ANPSR1CYP2C19CYP3A4
SCHEMBL8320252 0.83 ALDH1A1 (0.46) POLBLMNAALDH1A1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed